FDA

Enforcement Report

The FDA Enforcement Report is published weekly by the Food and Drug Administration, U.S. Public Health Service, Department of Health and Human Services. It contains information on actions taken in connection with agency regulatory activities.

November 6, 1996                                     96-45

RECALLS AND FIELD CORRECTIONS:  FOODS -- CLASS I ============
_______________
PRODUCT        Entenmann's Chocolate Chip Cookies, in 12
               ounce boxes.  Recall #F-028-7.
CODE           B1004 HW manufactured on 9/18/96.
MANUFACTURER   Entenmann's Inc., Miami, Florida.
RECALLED BY    C.P.C. Baking Business (doing business as
               Entenmann's, Inc.), Bay shore, New York, by
               press release and by notifying the Food
               Allergy Network, on September 24, 1996,
               followed by letter.  Firm-initiated recall
               ongoing.
DISTRIBUTION   Florida, Georgia, North Carolina, South
               Carolina, Virginia.
QUANTITY       3,732 boxes were distributed.
REASON         Product contains undeclared walnuts and nonfat
               dry milk.

_______________
PRODUCT        Various flavors and varieties of ice cream, in
               3 gallon tubs, half gallon and quart size
               plastic containers:
               (a) Maple Walnut Ice Cream
               (b) Butter Pecan Ice Cream
               (c) Chocolate Peanut Buttercup Ice Cream.
               Recall #F-029/031-7.
CODE           All misbranded product.
MANUFACTURER   M.B.B. Annis Dairy of Avon, Inc., Avon, New
               York.
RECALLED BY    Manufacturer, by telephone on September 20,
               1996.  Firm-initiated recall ongoing.
DISTRIBUTION   New York.
QUANTITY       (a) 119 3-gallon, 23 half-gallon, 15 quart
               size containers; (b) 88 3-gallon, 15 half-
               gallon, 3 quart size containers; (c) 51 3-
               gallon size containers were distributed.
REASON         The products bear partial ingredient
               statements which list the ice cream base
               ingredients only.  The nuts in these products
               are not listed in the ingredient statement and
               there is a potential for consumers sensitive
               to the nuts to think the product is merely
               flavored and does not contain the actual
               allergen.  Product a) contains walnuts;
               product b) contains pecans; product c)
               contains peanuts.


RECALLS AND FIELD CORRECTIONS:  FOODS -- CLASS II ===========
_______________
PRODUCT        Pastry Dough Shells (Discos), packaged in
               plastic bags of 10, under the Rico, Delicia,
               and Goya labels.  Recall #F-024-7.
CODE           None.  All misbranded product is under recall.
MANUFACTURER   Rico Products Company, Paterson, New Jersey,
RECALLED BY    Manufacturer, by telephone on June 18-19,
               1996.  Firm-initiated recall complete.
DISTRIBUTION   New Jersey, New York, Massachusetts,
               Connecticut, Pennsylvania, District of
               Columbia.
QUANTITY       Firm estimates none remains on the market.
REASON         Product contains undeclared FD&C Yellow No. 5.

_______________
PRODUCT        Goya Cola Champagne, in 355 ml (12 fluid
               ounce) glass bottles.  Recall #F-025-7.
CODE           Lot number 20895.
MANUFACTURER   The Lion Brewery, Wilkes-Barre, Pennsylvania.
RECALLED BY    Goya Foods, Inc., Secaucus, New Jersey, by
               telephone on June 21-25, 1996.  Completed
               recall resulted from  sample analysis and
               follow up by the New York State Department of
               Agriculture Markets.
DISTRIBUTION   New Jersey, Massachusetts.
QUANTITY       Approximately 2,020 cases were distributed;
               firm estimates none remains on the market.
REASON         Product contained undeclared FD&C Yellow No. 5
               and FD&C Yellow No. 6.

                             -2-_______________
PRODUCT        Tofutti brand Non Dairy Original Premium
               Frozen Dessert, Chocolate Cookie Crunch
               Flavor, in 1-pint containers.  
               Recall #F-027-7.
CODE           42097-42698 and 42097-62698.
MANUFACTURER   Kemps Foods, Inc., Lancaster, Pennsylvania.
RECALLED BY    Tofutti Brands, Inc., Cranford, New Jersey, by
               telephone followed by letter dated July 23,
               1996, and by press release dated June 19,
               1996.  Firm-initiated recall complete.
DISTRIBUTION   Nationwide and international.
QUANTITY       2,880 units were distributed; firm estimates
               none remains on the market.
REASON         Product contained undeclared almonds.

_______________
PRODUCT        Various flavors and varieties of ice cream, in
               3 gallon tubs, half gallon and quart size
               plastic containers:
               (a) Toffee Bar Krunch Ice Cream
               (b) Chocolate Almond Ice Cream
               (c) Pistachio Almond Ice Cream
               (d) Bubble Gum Ice Cream.  
               Recall #F-032/035-7.
CODE           All misbranded product.
MANUFACTURER   M.B.B. Annis Dairy of Avon, Inc., Avon, New
               York.
RECALLED BY    Manufacturer, by telephone on September 20,
               1996.  Firm-initiated recall ongoing.
DISTRIBUTION   New York.
QUANTITY       (a) 58 3-gallon, 6 half-gallon; (b) 214 3-
               gallon, 17 half-gallon, 10 quart size
               containers; (c) 69 3-gallon, 8 half-gallon
               size containers; (d) 65 3-gallon, 1 half-
               gallon size containers were distributed. 
REASON         The products bear partial ingredient
               statements which list the ice cream base
               ingredients only.  The nuts or color additive
               in these products are not listed in the
               ingredient statement and there is a potential
               for consumers sensitive to the nuts to think
               the product is merely flavored and does not
               contain the actual allergen. Products (a),
               (b), and (c) contain almonds; and product (d)
               contains FD&C Yellow No. 5.


RECALLS AND FIELD CORRECTIONS:  FOODS -- CLASS III ==========
_______________
PRODUCT        Minute Maid Premium Calcium-Rich Orange Juice,
               in 64 ounce gable-top cartons.
               Recall #F-026-7.
                             -3-CODE           Lot Number:
               Container:  OCT22PWY XXX CT349
                           Y= A,B or Filler
                           XXXX= Time
               Shipping Case:  OCT22T33407B.
MANUFACTURER   Coca-Cola Foods, Paw Paw, Michigan.
RECALLED BY    Coca-Cola Foods, Houston, Texas, by telephone
               on August 30, 1996.  Firm-initiated recall
               complete.
DISTRIBUTION   Wisconsin, Michigan, Pennsylvania, Iowa,
               Illinois, Kentucky, Ohio, Minnesota, Nebraska,
               Indiana, Missouri.
QUANTITY       4,425 cases were distributed.
REASON         Product is contaminated with yeast.


RECALLS AND FIELD CORRECTIONS:  DRUGS -- CLASS II ===========
_______________
PRODUCT        Sulfatrim Pediatric Suspension
               (Sulfamethoxazole and Trimethoprim, USP), in
               one pint bottles, used for the treatment of
               urinary infections due to susceptible organism
               strains, for the treatment of acute otitis
               media in children due to susceptible strains
               of streptococcus pneumoniae or haemophilus
               influenzae, under the Barre-National and
               Schein Pharmaceutical labels.  
               Recall #D-027-7.
CODE           Lot #RJ4459 0364-2077-16.
MANUFACTURER   Alpharma, U.S. Pharmaceuticals Divisions, also
               known as Barre-National, Inc., Baltimore,
               Maryland.
RECALLED BY    Manufacturer, by letter on or about June 3,
               1996.  Firm-initiated recall ongoing.
DISTRIBUTION   New York.
QUANTITY       3,948 Schein labeled product was distributed.
REASON         Some units may appear brown in color with a
               licorice flavor instead of red and cherry-
               flavored.  Taste/color change may be caused by
               degradation.

_______________
PRODUCT        Glaxo Wellcome brand (a) Zovirax Sterile
               Powder for Injection (Acyclovir Sodium), 1000
               mg/vial, in 20 ml vials, used in the treatment
               of herpes; (b) Mivacron Injection (Mivacurium
               Chloride), in 2 mg/ml, 20 ml multi-dose vials
               for IV administration, a non-depolarizing
               skeletal muscle relaxant.  
               Recall #D-029/030-7.

                             -4-CODE           Lot numbers:  (a) 5W3017, 5W3018, 5X3021.  A
               portion of lot 5W3017 was packaged and
               distributed in Canada as lot #5K190;
               (b) Lot numbers:  5S3014, 602362, 6S1819.
               A portion of lot #602362 was packaged and
               distributed in Canada as lot #6E592.
MANUFACTURER   Glaxo Wellcome, Inc., Research Triangle Park,
               North Carolina.
RECALLED BY    Manufacturer, by letter delivered during the
               week of October 21, 1996.  Firm-initiated
               recall ongoing.
DISTRIBUTION   Nationwide and Canada.
QUANTITY       (a) Lot 5W3017 - 23,470 vials in the U.S. and
               12,107 vials in Canada; estimate none remains
               on the market;   25,240 vials of lot 5W3018 in
               the U.S., estimate none remains on the market. 
               There were 35,520 vials of lot 5X3021
               distributed in the U.S., firm estimates 15,000
               remain on the market; (b) Lot 5S3014 -- 
               44,810 vials were distributed in the U.S. and
               estimate none to be on the market;  25,900
               vials of lot 6O2362 were distributed in the
               U.S. and 4,800 in Canada, firm estimate 13,000
               vials to be on the market in the U.S. and
               1,000 on the market in Canada; 54,160 vials of
               lot 6S1819 distributed in the U.S., with an
               estimated 11,000 vials still on the market.
REASON         (a) Defects in the glass vials may result in
               product contamination and/or problems with
               reconstitution; (b) Defects in the glass may
               result in product contamination.


RECALLS AND FIELD CORRECTIONS:  DRUGS -- CLASS III ==========
_______________
PRODUCT        Imipramine Hydrochloride Tablets, USP, 10 mg,
               in bottles of 100 and 1000, Rx for the relief
               of symptoms of depression, under the following
               labels:  Par Pharmaceutical, United Research
               Laboratories, Martec Pharmaceutical, Parmed
               Pharmaceutical.  Recall #D-028-7.
CODE           control number C28494, EXP 9/96. 
MANUFACTURER   Par Pharmaceutical, Inc., Spring Valley, New
               York.
RECALLED BY    Manufacturer, by letter on July 11, 1996. 
               Firm-initiated recall complete.
DISTRIBUTION   Nationwide and Puerto Rico.
QUANTITY       1,250 bottles of 100 and 279 bottles of 1000
               tablets were distributed; firm estimated that
               little or no product remained on market at
               time of recall initiation.

                             -5-REASON         Product is not stable:  This lot failed
               dissolution test (72%; Spec is NLT 75%) at the
               12-month stability timepoint.

_______________
PRODUCT        Purepac Pharmaceutical brand Metoprolol
               Tartrate Tablets, USP 50 mg, in bottles of
               1000, Rx indicated for the treatment of
               hypertension and angina.  Recall #D-031-7.
CODE           Lot #187A6 EXP 2/98.
MANUFACTURER   Faulding Pharmaceutical Company (Purepac
               Pharmaceutical Co.), Elizabeth, New Jersey.
RECALLED BY    Manufacturer, by letter on July 19, 1996. 
               Firm-initiated recall ongoing.
DISTRIBUTION   Nationwide.
QUANTITY       1,128 bottles were distributed; firm estimated
               that 980 bottles remained on market at time of
               recall initiation.
REASON         Some tablets may be overweight and
               superpotent.

_______________
PRODUCT        Cimetidine Tablets, USP, 800 mg; an oral Rx
               drug used in the treatment of ulcers, erosive
               gastroesophageal reflux disease, and the
               treatment of pathological hypersecretory
               conditions; packaged under the following
               labels and package sizes:
               (a) Novopharm, manufactured for: Novopharm
               USA, Schaumburg, IL, in 500 tablet bottles, 
               (b) H.L. Moore, distributed by: H.L. Moore
               Drug Exchange, New Britain, Conn., in 100
               tablet bottles
               (c) W/C Warner Chilcott, manufactured for
               Warner Chilcott Labs, Div. of Warner-Lambert
               Co., Morris Plains, NJ USA, in 100 tablet 
               bottles
               (d) Schein Pharmaceutical Inc., manufactured
               for Schein Pharmaceutical, Inc., Florham Park,
               NJ 07932 USA, in 100 tablet bottles
               (e) Martec Pharmaceutical Inc.; manufactured
               for Martec Pharmaceutical, Inc., Kansas City,
               MO in 100 tablet bottles
               (f) GG, distributed by Geneva Pharmaceuticals,
               Inc., Broomfield, CO, in 100 tablet bottles, 
               (g) Warrick Pharmaceuticals, Manufactured by:
               Novopharm Ltd., Toronto, Canada, Warrick
               Pharmaceuticals Corporation, Niles, Illinois,
               in 100, 500, and 1000 tablet bottles.  
               Recall #D-032-7.

                             -6- CODE          Lot 55476 EXP 1/97.  Note: The lot number has
               various suffixes, dependent on the bottle
               size, i.e. 55476A, 55476B, 5547640, 5547670,
               and 5547680.
MANUFACTURER   Novopharm Ltd., Scarborough, Ontario, Canada. 
RECALLED BY    Novopharm USA, Inc., Schaumburg, Illinois, by
               letter dated October 18, 1996.  Firm-initiated
               recall ongoing.
DISTRIBUTION   Nationwide.
QUANTITY       9,010 bottles of 100 tablets, 698 bottles of
               500 tablets and 265 bottles of 1000 tablets
               were distributed, with the firm estimating
               that very little, if any, remains on the
               market. 
REASON         Lot failed dissolution test at the 18-month
               stability timepoint.

_______________
PRODUCT        Parke-Davis brand Phenelzine Sulfate Tablets,
               USP Nardil, 15 mg, in bottles of 100, Rx used
               in the treatment of depression.  
               Recall #D-033-7.
CODE           Lot #07425D.
MANUFACTURER   The Park-Davis Division of Warner-Lambert
               Company, Morris Plains, New Jersey.
RECALLED BY    Manufacturer, by letter on June 17, 1996. 
               Firm-initiated recall ongoing.
DISTRIBUTION   Nationwide.
QUANTITY       18,432 bottles were distributed.
REASON         Lot failed content assay (subpotent) at the
               12-month stability timepoint.

_______________
PRODUCT        Parke-Davis brand Procanbid, Procainamide HCl
               Extended Release Tablets, 1000 mg, Rx, in
               bottles of 60, indicated for the treatment of
               documented ventricular arrhythmias.
               Recall #D-034-7.
CODE           Lot #788N5D EXP 8/98.
MANUFACTURER   The Parke-Davis Division of Warner-Lambert
               Company, Morris Plains, New Jersey.
RECALLED BY    Manufacturer, by letter on June 18, 1996. 
               Firm-initiated recall ongoing.
DISTRIBUTION   Nationwide.
QUANTITY       9,747 bottles were distributed; firm estimates
               none remains on the market.
REASON         Lot failed dissolution test (low at the 8-hour
               interval) at the 3-month stability timepoint.


                             -7-RECALLS AND FIELD CORRECTIONS:  BIOLOGICS -- CLASS I ========
_______________
PRODUCT        Albuminar Albumin (Human), U.S.P, (a)
               Albuminar - 25 (Albumin 25%, Human, USP); (b)
               Albuminar - 5 (Albumin 5%, Human, USP).  
               Recall #B-001/002-7.
CODE           (a) 25%  50 ml - lot P61205 EXP 12 MAY 99,
               M60902 EXP 09 FEB 97, M54512 EXP 02 DEC 97;
               100 ml - lot L58211 EXP 12 NOV 96, M61403 EXP
               28 FEB 97, M63204 EXP 14 APR 97, M54912 
               EXP 05 DEC 97, P61805, EXP 22 MAY 99.
               (b) 5%  50 ml - lot P18607 EXP 26 JUN 99
               500 ml - lot L8212 EXP 20 DEC 96.
MANUFACTURER   Centeon L.L.C., Kankakee Industrial
               Operations, Kankakee, Illinois.
RECALLED BY    Centeon L.L.C., King of Prussia, Pennsylvania, 
               by telephone on September 20 and 23, 1996,
               followed by letter.  Firm-initiated recall
               ongoing.  See also FDA talk papers T96-65,
               October 3, 1996, and T96-69, October 9, 1996.
DISTRIBUTION   Nationwide and international.
QUANTITY       18,508  50-ml vials and 1,677  500-ml vials of
               5%, and 52,759 50-ml vials and 42,957 100-ml
               vials of 25% were distributed.  The firm
               estimates that 18,000 vials remained on market
               at time of recall initiation. 
REASON         Biological products which either tested
               positive for Enterobacter cloacae and is
               associated with cases of septicemia or the
               vials may have been damaged during product
               handling possibly resulting in cracked vials. 
               Cracked vials have the potential for microbial
               contamination.


RECALLS AND FIELD CORRECTIONS:  BIOLOGICS -- CLASS II =======
_______________
PRODUCT        (a) Red Blood Cells; (b) Cryoprecipitated AHF.
               Recall #B-032/033-7.
CODE           Unit #KC34846.
MANUFACTURER   Virginia Blood Services, Richmond, Virginia.
RECALLED BY    Manufacturer, by telephone on February 8,
               1996. March 12, 1996.  Firm-initiated recall
               complete.
DISTRIBUTION   Virginia. 
QUANTITY       1 unit of each component was distributed.
REASON         Blood products tested negative for the
               antibody to the human T-lymphotropic virus
               type I (anti-HTLV-I), were collected from a
               donor who previously tested repeatedly
               reactive for anti-HTLV-1, Western blot
               indeterminate, and RIPA reactive.

                             -8-RECALLS AND FIELD CORRECTIONS:  BIOLOGICS -- CLASS III ======
_______________
PRODUCT        Recovered Plasma.  Recall #B-034-7.
CODE           Unit #KC34846.
MANUFACTURER   Virginia Blood Services, Richmond, Virginia.
RECALLED BY    Manufacturer, by fax on March 12, 1996.  Firm-
               initiated recall complete.
DISTRIBUTION   Switzerland.
QUANTITY       1 unit was distributed.
REASON         Blood product tested negative for the antibody
               to the human T-lymphotropic virus type I
               (anti-HTLV-I), but was collected from a donor
               who previously tested repeatedly reactive for
               anti-HTLV-1, Western blot indeterminate, and
               RIPA reactive.

_______________
PRODUCT        Red Blood Cells.  Recall #B-035-7.
CODE           Unit numbers:  4435375 and 4435381.
MANUFACTURER   Inland Northwest Blood Center, Spokane,
               Washington.
RECALLED BY    Manufacturer, by letter dated July 12, 1995. 
               Firm-initiated recall complete.
DISTRIBUTION   Washington state.
QUANTITY       2 units were distributed.
REASON         Blood products were collected from donors for
               which donor suitability was not adequately
               determined.


RECALLS AND FIELD CORRECTIONS:  DEVICES -- CLASS II =========
_______________
PRODUCT        Surgitek and Microvasive brand Gastrostomy
               feeding tube kits:
               (a) (Surgitek) Surgi-Peg Initial Placement
               Gastrostomy Tray,  Pull System, 15 FR size;
               (b) Surgi-Peg Replacement Gastrostomy Device,
               15 FR size; and the Microvasive brand, Initial
               Placement Gastrostomy Kit, Pull Method, 15 FR
               size, and the Microvasive brand, Initial
               Placement Gastrostomy Kit, Guidewire Method,
               15 FR size.  Recall #Z-030/031-7.
CODE           (a) (Surgitek) Surgi-Peg Pull System, Product
               Code #1101115, Box Lot #9505412, Tray Lot
               #9562511; (Microvasive) Pull Method, Product
               Code #6415, Box Lot #9625101 and #957312, Tray
               Lot #9562611 and #9512512; (Microvasive)
               Guidewire Method, Product Code #6416, Box Lot
               #9653901, #9627501, and #9627801, Tray
               Lot #9560012 and #9557712;
               (b) Product Code #1102315, Box Lot #9626001,
               Tray Lot #9523812.

                             -9-MANUFACTURER   Applied Medical Technology, Independence,
               Ohio.
RECALLED BY    Manufacturer, by letter dated January 24,
               1996.  Firm-initiated recall complete.
DISTRIBUTION   Massachusetts and Wisconsin.
QUANTITY       Firm estimates none remains on the market.
REASON         The bolsters used for these kits had been
               punched with 20FR holes rather than the
               correct 15FR holes.

_______________
PRODUCT        Surgitek brand Surgi-Peg Initial Placement
               Gastrostomy Tray - Pull System, 15 FR size,
               gastrostomy feeding tube kits.  
               Recall #Z-032-7.
CODE           Product #1101115, box lot #9520108, tray lot
               #9530307.
MANUFACTURER   Applied Medical Technology, Independence,
               Ohio.
RECALLED BY    Manufacturer, by letter dated October 5, 1995,
               and by telephone on September 30, 1996.  Firm-
               initiated recall complete.
DISTRIBUTION   Wisconsin.
QUANTITY       Firm estimates none remains on the market.
REASON         The bolsters used for these kits had been
               punched with 20FR holes rather than the
               correct 15FR holes.

_______________
PRODUCT        Signature Edition Infusion Pumps, Models 7100
               and 7200.  Recall #Z-034/035-7.
CODE           All pumps.
MANUFACTURER   Ivac Medical Systems, Inc. San Diego,
               California.
RECALLED BY    Manufacturer, by recall notification dated
               August 8, 1996.  Firm-initiated recall
               complete.
DISTRIBUTION   Nationwide.
QUANTITY       4,069 units were distributed.
REASON         A defective pressure sensing system causes the
               pump to alarm and shutdown, and in some
               situations not restart until the instrument is
               serviced.

_______________
PRODUCT        Sterile Gauze Sponges, 4" x 4", Reorder #4482. 
               Recall #Z-057-7.
CODE           Lot #1407122.
MANUFACTURER   China National Medicines & Health Products
               Import & Export Corporation, Yangzhou, China.
RECALLED BY    Dav-Mar Medical Products, Inc. (D.M.M.P.),
               Yonkers, New York, by letter dated September
               17, 1996.  Firm-initiated recall ongoing.
                            -10-DISTRIBUTION   New York, New Jersey, Connecticut.
QUANTITY       1,355 cases were distributed; firm estimates
               none remains on the market.
REASON         Sponges were found to be non-sterile by FDA
               analysis.

_______________
PRODUCT        Newport Breeze Ventilator, Model #E150. 
               Recall #Z-058-7.
CODE           Serial numbers 8908BR021J through 8908BR021J
               and 8903BR001 through 9103JB100.
MANUFACTURER   Newport Medical Instruments, Inc., Costa Mesa,
               California.
RECALLED BY    Manufacturer, by letter June 28, 1991.  Firm-
               initiated recall complete.
DISTRIBUTION   Nationwide and international.
QUANTITY       752 units were distributed.
REASON         The diaphragm on the spontaneous flow valve
               may rupture or leak, possibly resulting in
               hypoxemia to the patient.

_______________
PRODUCT        Sphygmomanometer, blood pressure meter. 
               Recall #Z-060-7.
CODE           All lots shipped to Ciba-Geigy, Summit, NJ on
               or about August 1995.
MANUFACTURER   Kam Ma Trading Company, a subsidiary of Golden
               Pacific Industrial Ltd., Tsuen Wan, Hong Kong.
RECALLED BY    BHS International, Crofton, Maryland
               (importer), by letter dated September 23,
               1996.  Firm-initiated recall ongoing.
DISTRIBUTION   Nationwide.
QUANTITY       27,000 units were distributed.
REAS0N         The device was being marketed without a
               cleared premarket notification submission
               under section 510(k) of the Act.


RECALLS AND FIELD CORRECTIONS:  DEVICES -- CLASS III ========
_______________
PRODUCT        BacT/View Software Version A.00, distributed
               as a part of the BacT/VIEW Manual/Software
               Assemblies, Part numbers 22105-16 and 22111-4,
               used with Organon Teknika's BacT/Alert and
               MB/Bact Microbial Detection Systems' data     
               management system.  Recall #Z-038-7.
CODE           All units.
MANUFACTURER   Organon Teknika, Oklahoma, City, Oklahoma.
RECALLED BY    Manufacturer, by issuing a "Technical Bullet"
               dated September 5, 1996, and by letter
               September 13, 1996.  Firm-initiated field
               correction complete.

                            -11-DISTRIBUTION   Nationwide.
QUANTITY       34 domestic BacT/Alert and MB/AacT units had
               been upgraded with BacT/VIEW A.00 software.
REASON         The computerized data bases of BacT/Alert and
               MB/BacT Microbiological Detection Systems
               running BacT/VIEW software may become
               corrupted and the system may stop reporting
               sample results.

_______________
PRODUCT        Total Bilirubin Test Kit, for the quantitative
               determination of total bilirubin in serum. 
               Recall #Z-039-7.
CODE           Lot numbers:  60941 EXP 4/98 and 61441 EXP
               5/98.
MANUFACTURER   Horizon Diagnostics, Inc., Ann Arbor,
               Michigan.
RECALLED BY    Manufacturer, by letter dated September 23,
               1996.  Firm-initiated recall ongoing.
DISTRIBUTION   Nationwide and international.
QUANTITY       1,135 kits were distributed.
REASON         Product may not contain a validated standard
               at the concentration stated on the label,
               which could yield inaccurate results.

_______________
PRODUCT        LuMax Cystometry System with Uroflow and
               Volume Infused Options, used to measure
               pressures in the bladder, abdomen, and urethra
               for the diagnosis of urinary incontinence,
               bladder outflow obstruction, and other bladder
               disorders.  Recall #Z-052-7.
CODE           Only units with the volume infused transducer
               option are affected.
MANUFACTURER   MedAmicus, Inc., Minneapolis, Minnesota.
RECALLED BY    Manufacturer, by letter on October 7, 1996. 
               Firm-initiated recall ongoing.
DISTRIBUTION   Alabama, California, Colorado, Florida,
               Georgia, Maryland, North Carolina, New York,
               Pennsylvania, Tennessee, Texas, Utah, West
               Virginia.
QUANTITY       23 units were distributed.
REASON         The amount of liquid infused into the bladder
               to perform tests may be recorded erroneously
               high.

_______________
PRODUCT        CLOTrac RACT Abnormal Coagulation Control,
               used to confirm the performance of Automated
               Coagulation Timers, or other versions and
               methodologies for performing a recalcified
               activated clotting time test.  
               Recall #Z-055-7.
                            -12-CODE           Lot #9608000094.
MANUFACTURER   Medtronic Blood Management, Parker, Colorado.
RECALLED BY    Manufacturer, by letter on September 23, 1996,
               followed by telephone on September 26-27,
               1996.  Firm-initiated recall ongoing.
DISTRIBUTION   California, Florida, Iowa, Michigan,
               Mississippi, New York, Texas, Washington
               state.
QUANTITY       36 boxes (540 units) were distributed.
REASON         The clotting range listed in the package
               insert for this lot number is higher than the
               actual clotting range for this control.  Use
               of this control will indicate that the device
               is out of calibration.

_______________
PRODUCT        Herpes Simplex Virus (HSV)-CF Antigen.
               Recall #Z-056-7.
CODE           Catalog #CF-02-05, Lot numbers 02009A and
               02011E1.
MANUFACTURER   Microbix Biosystems, Inc., Toronto, Ontario,
               Canada.
RECALLED BY    Manufacturer, by letter followed by telephone
               on August 22, 1996.  Firm-initiated recall
               complete.
DISTRIBUTION   Nationwide.
QUANTITY       11 vials.
REASON         Testing revealed a potential loss of
               stability.


RECALLS AND FIELD CORRECTIONS:  VETERINARY PRODUCTS -- CLASS II ====
_______________
PRODUCT        Cyanamid Aureomycin Sulmet Soluble Powder
               (chlortetracycline HCl and sulfamethazine
               bisulfate), in 4 ounce pouches, antibacterial
               for oral veterinary use in swine only.. 
               Recall #V-018-7.
CODE           Lot #950780 EXP 5/99.
MANUFACTURER   PM Resources, Inc., Bridgeton, Missouri.
RECALLED BY    American Cyanamid Company, Fort Dodge, Iowa,
               by letter on September 17, 1996.  Firm-
               initiated recall complete.
DISTRIBUTION   Indiana, Iowa, Missouri, Nebraska, North
               Carolina, Wisconsin.
QUANTITY       279 40-pouch pails were distributed.
REASON         Sulfamethazine levels were below
               specifications at 12 months stability.  Low
               sulfamethazine potency was attributed to low
               formulation by the manufacturer.

                            ####
END OF ENFORCEMENT REPORT FOR NOVEMBER 6, 1996.  BLANK PAGES MAY FOLLOW.
                                   -13-

End of Enforcement Report for
[FDA HOME PAGE]